Question 1

What specific benefits could I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer clinical trial (NCT00819754). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer clinical trial (NCT00819754). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer clinical trial (NCT00819754). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment or check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer clinical trial (NCT00819754). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer clinical trial (NCT00819754). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer clinical trial (NCT00819754). Contact the study team or your healthcare provider for specific answers.

What this study is about